Testing the PD-1 Antibody, MK3475, Given With Ziv-aflibercept in Patients With Advanced Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Washington University School of Medicine
Washington University School of Medicine
Vividion Therapeutics, Inc.
TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
Eli Lilly and Company
Pfizer
Dana-Farber Cancer Institute
University of California, Irvine
Imugene Limited
M.D. Anderson Cancer Center
Exelixis
Pfizer
Seagen Inc.
Tizona Therapeutics, Inc
Genentech, Inc.
Alnylam Pharmaceuticals
Amgen
IDEAYA Biosciences
H. Lee Moffitt Cancer Center and Research Institute
Novartis
M.D. Anderson Cancer Center
City of Hope Medical Center
Eli Lilly and Company
Seagen Inc.
Novartis
Amgen
Sairopa B.V.
Seattle Children's Hospital
Coherus Oncology, Inc.
Rondo Therapeutics
Tempest Therapeutics
Valo Therapeutics Oy
Epkin
Bicara Therapeutics
Xencor, Inc.
Incyte Corporation
Cardiff University
Leap Therapeutics, Inc.
Toray Industries, Inc
Trishula Therapeutics, Inc.
Trishula Therapeutics, Inc.
DEKA Biosciences
Compugen Ltd
Boehringer Ingelheim
Turnstone Biologics, Corp.
Merck Sharp & Dohme LLC
Sotio Biotech Inc.
Carisma Therapeutics Inc